XRP has been testing its resilience in recent months. After reaching $3.66 in July 2025, the coin slipped to $2.70 on September 1. Buyers immediately returned to the market, taking it back above $3.00. At the current press time, the token is trading at $3.02 with market players waiting to see where it will go […]XRP has been testing its resilience in recent months. After reaching $3.66 in July 2025, the coin slipped to $2.70 on September 1. Buyers immediately returned to the market, taking it back above $3.00. At the current press time, the token is trading at $3.02 with market players waiting to see where it will go […]

XRP Price Analysis: From $3 to Potential $36 With Historic Cup Breakout

2025/09/18 13:00
xrp
  • XRP trades at $3.02 after recovering from September lows.
  • Chart analysis points to a potential path toward $36 in the coming quarters.
  • A decade-long structure shift signals the start of a major uptrend.

XRP has been testing its resilience in recent months. After reaching $3.66 in July 2025, the coin slipped to $2.70 on September 1. Buyers immediately returned to the market, taking it back above $3.00. At the current press time, the token is trading at $3.02 with market players waiting to see where it will go next.

Source: CoinMarketcap

Dark Defender, a chartist who has a community following, thinks XRP’s current pattren is similar to what he believes to be the “flight of the phoenix.”

He thinks in his analysis that the token is probing a crucial level again for a potential massive surge. He felt a complete “cup pattern” formed by monitoring the long-term chart would take XRP to $36.

Also Read: XRP Holds $3 Support as Bulls Eye a Break Above $3.10

XRP Historical Patterns Support Bold Projection

Chart analysis by a defender aligns XRP’s price history into two long cup-like patterns. The first one, from 2013 to 2017, ended with a sharp surge once the resistance was eliminated. The second one, from 2018 to 2025, has itself just broken free from an eight-year bear trend.

The chart suggests that the token has moved out of distribution into expansion on a quarterly horizon. On a closing basis, for the first time in years, the lower trend line that capped rallies since 2018 has been broken.

Source: X

After the breakout, XRP corrected back into the same region, which is acting as support currently. Such a “break and retest” chart pattern is typically related to sustainable changes in trends.

It pinpoints major upside objectives: $5.86 as a starting level, $18.23 as a possible mid-stage objective, and $36.77 as a final extension should momentum be maintained. These levels represent Fibonacci goals commonly applied with technical trading.

Faster Path Points Toward $10–$18 in Coming Quarters

Even if things appear to be good, threats remain. A close below the $1.00 to $1.70 level would weaken the bull’s stand. Abandoning the long-term chart’s parabolic support curve would also be an exhaustion signal.

Baseline scenario suggests that XRP could consolidate within the $3 to $4 area before expanding to $6. A faster pathway could take the coin to $10 to $18 region within the next quarters. High-end goal $36 is seen as viable only if momentum is continuous and liquidity increases dramatically.

As seen with September’s trading showing resilience, investors currently wait for the final quarter of 2025 to see if XRP begins its much-anticipated phoenix rise.

Also Read: Will XRP Price Increase In September 2025?

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29